# Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

> **NCT02344680** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 303 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- HBV
- Fibrosis, Liver
- Cirrhosis, Liver
- Hepatocellular Carcinoma
- Hepatitis Delta Virus
- Alcoholic Hepatitis

## Interventions

- **DRUG:** Anti-HIV Agents

## Key facts

- **NCT ID:** NCT02344680
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-10
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2025-06-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02344680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02344680, "Liver Fibrosis in Zambian HIV-HBV Co-infected Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02344680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*